title: A rapidly growing lung mass with air crescent formation.
authors.affiliation: Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK. h.lota@rbht.nhs.uk
authors.forename: Harpreet K
authors.initials: HK
authors.lastname: Lota
authors.forename: Michael
authors.initials: M
authors.lastname: Dusmet
authors.forename: Katrine
authors.initials: K
authors.lastname: Steele
authors.forename: Athol U
authors.initials: AU
authors.lastname: Wells
authors.forename: Andrew G
authors.initials: AG
authors.lastname: Nicholson
authors.forename: David M
authors.initials: DM
authors.lastname: Hansell
authors.forename: Elisabetta A
authors.initials: EA
authors.lastname: Renzoni
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols; D003520:Cyclophosphamide; D018450:Disease Progression; D004317:Doxorubicin; D006801:Humans; D016867:Immunocompromised Host; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008230:Lymphomatoid Granulomatosis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011241:Prednisone; D000069283:Rituximab; D014057:Tomography, X-Ray Computed; D014750:Vincristine
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone